Investment Summary |
|
|---|---|
| Date | 2022-03-15 |
| Target | LASEA |
| Sector | Machinery |
| Investor(s) | M80 Partners |
| Deal Type | Growth Capital |
SEARCH BY
M80 Partners is a private equity firm focused on acquiring and investing in companies across France and the Benelux. The Firm targets companies valued from €25 to €250 million where it can commit €10 to €60 million equity. Broad areas of interest include consumer, healthcare, business services, and manufacturing. M80 Partners was established in 2018 and is headquartered in Brussels, Belgium.
| DEAL STATS | # |
|---|---|
| Overall | 10 of 11 |
| Sector: Machinery M&A | 1 of 1 |
| Type: Growth Capital M&A Deals | 4 of 4 |
| Country: Belgium M&A | 4 of 5 |
| Year: 2022 M&A | 2 of 3 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-01-13 |
Access Vision
Paris, France Access Vision is a french chain of ophthalmology centers, providing extensive diagnostic care, as well as simple laser surgery. Access Vision was founded in 2018 and is based in Paris, France. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-05-01 |
Strapharm
Saint-Hilaire-de-Loulay, France Strapharm is a contract development and manufacturing company for food supplements. The company supplies major food supplement brands and large retailers in France and internationally. Strapharm covers the full range of food and dietary supplements and has significant expertise in products for supporting immunity, supporting sports performance and the health and vitality of pets. Strapharm was founded in 1987 and is based in France. |
Sell | - |
